| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $398K | -74.1% |
| R&D Expense | $18.4M | -57.9% |
| SG&A Expense | $11.5M | -37.6% |
| Operating Income | -$31.0M | +67.8% |
| Pre-tax Income | -$28.9M | +69.0% |
| Income Tax | $11K | -71.8% |
| Net Income | -$28.9M | +69.0% |
| EPS (Basic) | -$18.62 | -1202.1% |
| EPS (Diluted) | -$18.62 | -1202.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $15.9M | -60.8% |
| Short-term Investments | $0 | — |
| Current Assets | $16.3M | -62.2% |
| Total Assets | $36.1M | -45.6% |
| Current Liabilities | $9.5M | -24.6% |
| Total Liabilities | $46.8M | -14.5% |
| Stockholders' Equity | -$10.7M | -192.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$28.9M | +58.8% |
| Capital Expenditures | $116K | -95.0% |
| Investing Cash Flow | -$98K | -100.1% |
| Financing Cash Flow | $4.3M | -49.9% |
| Free Cash Flow | -$29.0M | +60.0% |